100% SVR with 8 weeks of ledipasvir/sofosbuvir in HIV-infected Men with Acute HCV Infection: Results from the SWIFT-C Trial (Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals)
Publication
, Conference
Naggie, S; Fierer, DS; Hughes, M; Kim, AY; Luetkemeyer, A; Vu, V; Roa, J; Brainard, DM; McHutchison, JG; Peters, MG; Kiser, JJ; Marks, KM; Chung, RT
Published in: HEPATOLOGY
October 1, 2017
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2017
Volume
66
Start / End Page
113A / 113A
Location
Washington, DC
Publisher
WILEY
Conference Name
68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Naggie, S., Fierer, D. S., Hughes, M., Kim, A. Y., Luetkemeyer, A., Vu, V., … Chung, R. T. (2017). 100% SVR with 8 weeks of ledipasvir/sofosbuvir in HIV-infected Men with Acute HCV Infection: Results from the SWIFT-C Trial (Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals). In HEPATOLOGY (Vol. 66, pp. 113A-113A). Washington, DC: WILEY.
Naggie, Susanna, Daniel S. Fierer, Michael Hughes, Arthur Y. Kim, Anne Luetkemeyer, Vincent Vu, Jhoanna Roa, et al. “100% SVR with 8 weeks of ledipasvir/sofosbuvir in HIV-infected Men with Acute HCV Infection: Results from the SWIFT-C Trial (Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals).” In HEPATOLOGY, 66:113A-113A. WILEY, 2017.
Naggie S, Fierer DS, Hughes M, Kim AY, Luetkemeyer A, Vu V, et al. 100% SVR with 8 weeks of ledipasvir/sofosbuvir in HIV-infected Men with Acute HCV Infection: Results from the SWIFT-C Trial (Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals). In: HEPATOLOGY. WILEY; 2017. p. 113A-113A.
Naggie, Susanna, et al. “100% SVR with 8 weeks of ledipasvir/sofosbuvir in HIV-infected Men with Acute HCV Infection: Results from the SWIFT-C Trial (Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals).” HEPATOLOGY, vol. 66, WILEY, 2017, pp. 113A-113A.
Naggie S, Fierer DS, Hughes M, Kim AY, Luetkemeyer A, Vu V, Roa J, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Marks KM, Chung RT. 100% SVR with 8 weeks of ledipasvir/sofosbuvir in HIV-infected Men with Acute HCV Infection: Results from the SWIFT-C Trial (Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals). HEPATOLOGY. WILEY; 2017. p. 113A-113A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2017
Volume
66
Start / End Page
113A / 113A
Location
Washington, DC
Publisher
WILEY
Conference Name
68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics